Henry Schein to distribute COVID-19 rapid test kit

LabPulse.com staff writers
Mar 31, 2020
2020 03 06 18 55 2739 Virus Coronavirus China2 400

Henry Schein has become the exclusive U.S. distributor of a second point-of-care rapid test kit for the novel coronavirus.

Henry Schein is working with Becton Dickinson and BioMedomics to make the test kits available to healthcare professionals for detecting antibodies associated with COVID-19 in as few as 15 minutes. More specifically, the BioMedomics test analyzes blood, serum, or plasma samples for the presence of immunoglobulin M (IgM) and immunoglobulin G (IgG) antibodies associated with SARS-CoV-2 in four steps.

Last week, Henry Schein announced the availability of the Standard Q COVID-19 IgM/IgG rapid test, which is also administered at the point of care and delivers results within 15 minutes.

Latest in COVID-19
Long Covid Word Cloud Social
Long COVID symptoms reported by 17% of unvaccinated people
June 1, 2023
Coronavirus Mutation Social
COVID-19’s 'long tail' analyzed at European rheumatology congress
May 31, 2023
Visit our Molecular Diagnostics Community
Sponsored
Visit our Molecular Diagnostics Community
May 11, 2023
Covid 19 Global Financial Crisis Social
NIH-backed project develops scoring system for identifying long-COVID patients
May 25, 2023
Related Stories
2020 05 06 16 03 1866 Henry Schein 2019 400
Financial Results
Henry Schein sees growth in Q1 sales, profit
2020 02 25 17 48 0053 Thumbs Up New 400
PCR
Ipsum gets FDA nod for COVID-19 test
2020 03 26 20 17 4007 Henry Schein 2019 400
Health Topics
Henry Schein develops rapid antibody blood test for COVID-19
Visit our Molecular Diagnostics Community
Sponsor Content
Visit our Molecular Diagnostics Community
More in COVID-19
Long COVID symptoms reported by 17% of unvaccinated people
One in six unvaccinated people report persistent health impacts from COVID-19 two years after a confirmed SARS-CoV-2 infection.
June 1, 2023
Long Covid Word Cloud Social
COVID-19’s 'long tail' analyzed at European rheumatology congress
EULAR’s 2023 Congress includes presentations on iRD patients’ susceptibility to long COVID, and COVID-19 vaccination safety in pregnant and breastfeeding women with autoimmune disease.
May 31, 2023
Coronavirus Mutation Social
FDA grants full approval for antiviral pill to treat mild-to-moderate COVID-19 in adults
Paxlovid is the fourth drug — and first antiviral pill — approved by the FDA to treat COVID-19 in adults.
May 25, 2023
Fda Button Social
NIH-backed project develops scoring system for identifying long-COVID patients
While multiple earlier studies have assessed the effects of long COVID, previous efforts largely had retrospective designs, relied on electronic health record entries, and lacked an uninfected comparison group.
May 25, 2023
Covid 19 Global Financial Crisis Social
Domus Diagnostics gets $2.4M NIH grant to develop at-home molecular test
The award, granted as part of the NIH Rapid Acceleration of Diagnostics (RADx) Tech program, will support accelerated validation and scaling of a testing platform to prepare it for a clinical trial.
May 24, 2023
Money Bag Grant Award Social
Medical records link vaccination against COVID-19 to reduced risk of non-respiratory symptoms
An analysis, details of which were presented Tuesday at the ATS 2023 International Conference in Washington, DC, reviewed data from 63,454 patients who were treated in a University of California medical center for COVID-19.
May 23, 2023
Covid 19 Vaccine Distribution Transport Social
Antibody titer levels associated with protection against Omicron: Study
Immunoglobin G and neutralizing antibody titer levels were associated with protection against infection with the Omicron variant and against symptomatic disease.
May 23, 2023
Covid 19 Antibody Social
Masking and air cleaners reduced COVID-19 in two Swiss schools: Study
Face masks and portable air cleaners effectively reduced the spread of SARS-CoV-2, the virus that causes COVID-19, in two Swiss schools.
May 18, 2023
Children Facemask School Social
Masking should continue in healthcare settings, some experts say
Masking in healthcare settings should continue in order to optimize patient safety, recommend infectious disease experts in a commentary.
May 16, 2023
Doctors Masks Team Social
LumiraDx Q1 revenues drop 82% as its transition from non-COVID tests takes shape
In April, the company had announced a cost restructuring program involving a reduction of its global workforce by approximately 40%. It now expects to see the full impact of the restructuring activities during the third quarter.
May 16, 2023
Covid 19 Financial Chart Social
A closer look at long COVID symptoms
Intensively studied patients with persistent post-COVID neurological symptoms were found to have autonomic dysfunction and differences in their immune cell profiles.
May 10, 2023
Long Covid Word Cloud Social
FDA grants de novo request enabling the marketing of QuidelOrtho SARS-CoV-2 antibody tests
The tests are intended for prescription use only for the qualitative detection of IgG antibodies to SARS-CoV-2 to aid in identifying patients who have an adaptive immune response to SARS-CoV-2 from either a recent or prior infection.
May 10, 2023
Covid 19 Antibody Social
Page 1 of 32
Next Page